August 25–27, 2020
Delivered Digitally,
China Standard Time

Forge valuable cross-border partnerships at ChinaBio® Partnering Forum

At a time when face-to-face interactions are limited, we must find new approaches and creative solutions for fostering and maintaining the critical relationships that drive life science partnering, your company and much needed therapeutics forward.

Registration will open soon. Sign up for registration updates below!

Get the latest event updates

Download this exclusive report!

2018 finished with record-setting investments in the China life science sector, which sets the stage for valuable cross-border partnerships.

Download and review the full report.

Download your copy

ChinaBio Partnering Forum 2019 Speakers

Lee E. Babiss, PhD

CEO, Gotham Therapeutics Corp.; Co-Founder and President

SYNBLic Therapeutics Inc.

Joseph Benkert, MPP

Senior Advisor, National Security

Morrison & Foerster

Robert Braithwaite

CEO

Luqa Pharmaceuticals

Wei (William) Cao, PhD

Founder, Chairman and CEO

Gracell Biotechnologies Group

David Charles, MD

Chairman, Arena Therapeutics; Founder

Global Alliance for Patient Access

Alan Chen, MBA

Partner and Managing Director, Head of Private Equity

Ally Bridge

Thomas Chou, JD

Co-Head, Asia Private Equity Practice, Partner

Morrison & Foerster

Owen Cox, LLM

Foreign Counsel

Global Law Office, Shanghai

Gregory Frost, PhD

CEO

F1 Oncology

Jing He, MD, PhD

Head, Roche Pharma Development China

Roche

Lu Huang, MD, MBA

Managing Director

Morningside Ventures

Yong Jun Liu

Global Head of Research, Senior VP R&D

Sanofi

Brian Kennedy, JD

President

Woodberry Associates

Will Liu, PhD

Partner

Eight Roads Ventures

James Lu, JD

Partner

Cooley LLP, Shanghai

Astrid Maria Dahl, PhD, MBA

Executive Business Development Director, Oncology

AstraZeneca

Rama Padmanabhan, JD

Partner

Cooley LLP

Robert Phillips, JD

Partner

Cooley LLP

Don Qiu, PhD, MBA

Co-Founder and Senior VP, Business Development

CanSino Biologics Inc

Martin Shen, MBBS

President

Tencent Trusted Doctors

Sophie Sun, MBA

Managing Director, Merck China Innovation Hub; VP, Merck Strategy and Transformation China

Merck

George Wang, LLM

Senior Partner

Global Law Office, Shanghai

Dan Wang, MD, MBA

Head, Asia Pacific

Johnson & Johnson Innovation

Yu Wang, PhD

Of Counsel

Morrison & Foerster

Jonathan Wang, PhD, MBA

Partner, Founding Partner

OrbiMed, OrbiMed Asia

Ming Wang, PhD, MBA

Founder, President and CEO

Phanes Therapeutics

Hayato Watanabe, CFA

Senior VP, Head of Asia

Locust Walk

Zheng Wei, PhD

CEO and Co-Founder

Connect Biopharma

Min Wu, PhD, MBA

Executive Director, Search and Evaluation, Asia Pacific Innovation Hub, Business Development and Licensing

MSD R&D (China) Co., Ltd.

Dajun Yang, MD, PhD

Chairman and CEO

Ascentage Pharma

Richard Yeh, MBA

CFO

CStone

Debra Yu, MD

Managing Director, Head of Cross-Border Healthcare Investment Banking

China Renaissance

Bing Yuan, PhD, MBA

Senior VP and Global Head of Corporate Development

CStone Pharmaceuticals

Dan Zhang, MD, MPH

Executive Chairman

Fountain Medical Development Ltd

Faming Zhang, PhD

CEO

Waterstone Pharmaceuticals, Inc.

Michelle Xia, PhD

Chairman and CEO

Akeso Biopharma Inc.

Dennis A. Wong, MD

Head, Asia Pacific Development

Sanofi

Anna Zhu

VP, Global Issuer Services

HKEX

Yitian Luo

Managing Director

YunFeng Capital

Fay Xing, MD, MBA

CEO, Pica Health Venture Partner

6 Dimensions Capital

Jenny Liu, PhD

Chief Investment Officer

Livzon Pharmaceutical Group

Carl Firth, PhD, MBA

CEO

ASLAN Pharmaceuticals

Michael Yu

Hong Kong Solicitor, Represented Ascletis Pharma

1st Life Sciences HK IPO Under New Rules

See the full agenda

ELEVATE YOUR PARTNERING STRATEGY WITH LEADERS IN THE GLOBAL BIOTECH COMMUNITY

Meet more key decision makers in two days of partnering meetings than you could in one year.

Partnering Login Learn more

EBD GROUP AND CHINABIO® GROUP

Forge valuable cross-border partnerships at ChinaBio® Partnering Forum

At a time when face-to-face interactions are limited, we must find new approaches and creative solutions for fostering and maintaining the critical relationships that drive life science partnering, your company and much needed therapeutics forward.

Just in! ChinaBio® Partnering Forum will be delivered digitally!

Get the latest event updates

Download this exclusive report!

2018 finished with record-setting investments in the China life science sector, which sets the stage for valuable cross-border partnerships.

ChinaBio Partnering Forum 2019 Speakers

ELEVATE YOUR PARTNERING STRATEGY WITH LEADERS IN THE GLOBAL BIOTECH COMMUNITY

Meet more key decision makers in two days of partnering meetings than you could in one year.

EBD GROUP AND CHINABIO® GROUP

FACILITATING THE GROWTH OF THE LIFE SCIENCE INDUSTRY

Forge valuable cross-border partnerships at ChinaBio® Partnering Forum

At a time when face-to-face interactions are limited, we must find new approaches and creative solutions for fostering and maintaining the critical relationships that drive life science partnering, your company and much needed therapeutics forward.

Just in! ChinaBio® Partnering Forum will be delivered digitally!

Get the latest event updates

Download this exclusive report!

2018 finished with record-setting investments in the China life science sector, which sets the stage for valuable cross-border partnerships.

ChinaBio Partnering Forum 2019 Speakers

ELEVATE YOUR PARTNERING STRATEGY WITH LEADERS IN THE GLOBAL BIOTECH COMMUNITY

Meet more key decision makers in two days of partnering meetings than you could in one year.

2019 - Host Sponsor

2019 - Platinum Sponsors

2019 - Gold Sponsors

2019 - Silver Sponsors

2019 Exhibitors

Gala Reception Sponsor

Bootcamp Sponsor

EBD GROUP AND CHINABIO® GROUP

FACILITATING THE GROWTH OF THE LIFE SCIENCE INDUSTRY